Literature DB >> 9057056

Membranous nephropathy in primary antiphospholipid syndrome: description of a case and induction of renal injury in SCID mice.

Y Levy1, L Ziporen, B Gilburd, J George, S Polak-Charcon, H Amital, J Cledes, P Youinou, Y Shoenfeld.   

Abstract

Primary antiphospholipid syndrome (PAPS) is a recently recognized clinical entity encompassing the combination of thromboembolic phenomena, thrombocytopenia and recurrent abortions in the presence of antiphospholipid antibodies. We present a patient with PAPS accompanied by renal involvement, manifested as membranous nephropathy, as proven by a renal biopsy. To investigate further the possible association between PAPS and the renal lesions we attempted to induce similar renal manifestations by transferring peripheral blood lymphocytes (PBL) from this patient to severe combined immunodeficiency (SCID) mice. The mice transfused with PBL from the affected patient exemplified antiphospholipid antibodies (aPL) following which a renal lesion consistent with the human membranous nephropathy lesion was precipitated. This study substantiates the role of aPL as possible inducers of renal damage.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9057056

Source DB:  PubMed          Journal:  Hum Antibodies Hybridomas        ISSN: 0956-960X


  3 in total

1.  Renal involvement in primary antiphospholipid syndrome: retrospective analysis of 160 patients.

Authors:  Renato Alberto Sinico; Ilaria Cavazzana; Monica Nuzzo; Monica Vianelli; Pietro Napodano; Patrizia Scaini; Angela Tincani
Journal:  Clin J Am Soc Nephrol       Date:  2010-04-29       Impact factor: 8.237

2.  Primary antiphospholipid syndrome presenting as renal vein thrombosis and membranous nephropathy.

Authors:  Swasti Chaturvedi; Leonardo Brandao; Denis Geary; Christoph Licht
Journal:  Pediatr Nephrol       Date:  2011-03-23       Impact factor: 3.714

3.  Antiphospholipid syndrome nephropathy (APSN) in patients with lupus nephritis: a retrospective clinical and renal pathology study.

Authors:  Gian Luca Erre; Luisanna Bosincu; Rossana Faedda; Patrizia Fenu; Antonio Masala; Marcella Sanna; Loredana Taras; Maria Giovanna Longu; Marco Piras; Giovanni Soro; Andrea Ercole Satta; Giuseppe Passiu
Journal:  Rheumatol Int       Date:  2014-04       Impact factor: 2.631

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.